We examined the effects of short and prolonged exposure to carvedilol, an antihypertensive and ␤-adrenoceptor blocking drug, on voltage-dependent Na ϩ channels in cultured bovine adrenal medullary cells. Carvedilol (1-100 M) reduced 22
6 cells) (n ϭ 3, P Ͻ 0.05) without altering the K d value, suggesting a rise in the number of cell surface Na ϩ channels. The increase in [
3 H]STX binding by carvedilol was prevented by cycloheximide, an inhibitor of protein synthesis, whereas carvedilol changed neither ␣-nor ␤ 1 -subunit mRNA levels of Na ϩ channels. The carvedilol-induced increase of [ 3 H]STX binding was abolished by brefeldin A and H-89, inhibitors of intracellular vesicular trafficking of proteins from the trans-Golgi network and of cyclic AMP-dependent protein kinase (protein kinase A), respectively. The present findings suggest that short-term treatment with carvedilol reduces the activity of Na ϩ channels, whereas prolonged exposure to carvedilol up-regulates cell surface Na ϩ channels. This may add new pharmacological effects of carvedilol to our understanding in the treatment of heart failure and hypertension.
Carvedilol, an antihypertensive agent, possesses the pharmacological properties of ␤-adrenoceptor blocking action and direct vasodilating action (Ruffolo et al., 1990) . A series of investigations revealed that this agent possesses multiple actions, including those characteristic of a potent antioxidant, such as inhibition of superoxide release from human neutrophils and suppression of lipid peroxidation in rat brain homogenates (Yue et al., 1992) , cardioprotective action (Feuerstein and Ruffolo, 1996) , and inhibition of vascular smooth muscle cell proliferation (Ohlstein et al., 1993) . Carvedilol is also reported to have neuroprotective activity via inhibition of glutamate release and the N-methyl-D-aspartate receptor (Lysko et al., , 1994 . However, it has not been reported whether/how carvedilol affects ion channels in cardiac, vascular, or neuronal cells.
Voltage-dependent Na ϩ channels are responsible for the rising phase of the action potential in the membranes of neurons and most electrically excitable cells (for review, see Catterall, 1992) . Na ϩ channels consist of the principal ␣-subunit, which may be associated with a noncovalently attached ␤ 1 -subunit, and a disulfide-linked ␤ 2 -subunit (Klugbauer et al., 1995; Catterall, 2000) . The ␣-subunits issued from a large multigene family contain the ion-pore and the toxin binding sites, i.e., site 1 for tetrodotoxin (TTX) and saxitoxin (STX), site 2 for veratridine, site 3 for ␣-scorpion toxin, site 4 for ␤-scorpion toxin, and site 5 for Ptychodiscus brevis toxin-3 (PbTx-3) (Wada et al., 1992; Catterall, 2000) . Structures of ␤ 1 -subunit are similar among various tissues, but ␤ 2 -subunit is cloned only in the brain (Isom et al., 1995) . In adrenal medullary cells (Yamamoto et al., , 1997 , the Na ϩ channel ␣-subunits are homologous to the human neuroendocrine-type Na ϩ channel ␣-subunit (hNE-Na) (Klugbauer et al., 1995) , and the Na ϩ channel ␤ 1 -subunits are structurally similar to that of rat brain (Oh and Waxman, 1994) . Bovine adrenal medullary Na ϩ channels share many physiological and pharmacological properties with those of the human cells (Wada et al., 1985 (Wada et al., , 1992 . In the cells, veratridine caused catecholamine secretion, which was depen-dent on veratridine-induced 45 Ca 2ϩ influx via voltage-dependent Ca 2ϩ channels as well as 22 Na ϩ influx via voltagedependent Na ϩ channels (Wada et al., 1985) . In the regulation of Na ϩ channel expression, cyclic AMP-dependent protein kinase (protein kinase A) or activation of insulin receptors increased the cell surface density of Na ϩ channels without elevating Na ϩ channel mRNA levels. In contrast, chronic treatment with antiepileptic valproic acid increased both the density and mRNA of Na ϩ channels (Yamamoto et al., 1997) . In a previous study (Morita et al., 1989) , carvedilol inhibited the secretion of catecholamines induced by various secretagogues, by its stabilizing action on the plasma membranes rather than by its blocking action on Ca 2ϩ influx in bovine adrenal medullary cells. The aim of the present study was to investigate whether carvedilol directly interferes with Na ϩ influx mediated through voltage-dependent Na ϩ channels in cultured bovine adrenal medullary cells. In addition, the effects of prolonged exposure to carvedilol on the density of cell surface Na ϩ channel proteins and levels of Na ϩ channel mRNA were also evaluated in adrenal medullary cells. As a result, we found that carvedilol acutely reduces the functional activity of Na ϩ channels, followed by an increase in cell surface Na ϩ channels, without any change in levels of mRNA.
Experimental Procedures
Materials. Chemicals used were obtained from the following sources: Eagle's minimum essential medium (MEM), Nissui Pharmaceutical, Tokyo, Japan; calf serum, Nacalai Tesque, Kyoto, Japan; brefeldin A (BFA), cycloheximide, TTX, carbachol, veratridine, ␣-scorpion venom (Leiurus quinquestriatus quinquestriatus), and ␤-scorpion venom (Centruroides sculpturatus), Sigma-Aldrich, St. Louis, MO; PbTx-3, Latoxan, Westbury, NY; and collagenase, Nitta Zerachin Inc., Osaka, Japan. Carvedilol was kindly donated from Daiichi Pharmaceutical Co. Ltd., Tokyo, Japan. Plasmids containing hNE-Na (Klugbauer et al., 1995) and rat brain Na ϩ channel ␤ 1 -subunit cDNA (Oh and Waxman, 1994) (Yanagihara et al., 1994) . To remove nonchromaffin cells, such as fibroblasts or epithelial cells, the differential plating procedure was used, and the final cell preparation contained at least 80 to 90% chromaffin cells. The cells were cultured under 5% CO 2 /95% air in a CO 2 incubator and used for experiments within 3 to 5 days of culture. For prolonged exposure to carvedilol, cells were incubated with or without 10 M carvedilol in Eagle's MEM containing 10% calf serum for the various periods indicated. After treatment, the cells were washed three times with 1 ml of Krebs-Ringer phosphate buffer (see below) and used for the experiments. There was not a significant change in cell viability between control cells and cells treated with carvedilol. Carvedilol was dissolved in dimethyl sulfoxide (DMSO). To avoid the possible influence of DMSO on cells, all reaction media, including the control media, were standardized at a final concentration of 0.25% DMSO.
22 Na ؉ and 45 Ca 2؉ Influx. Oxygenated Krebs-Ringer phosphate (KRP) buffer was used throughout. It had the following composition: 154 mM NaCl, 5.6 mM KCl, 1.1 mM MgSO 4 , 2.2 mM CaCl 2 , 0.85 mM NaH 2 PO 4 , 2.15 mM Na 2 HPO 4 , and 10 mM glucose, adjusted to pH 7.4. Cells were incubated with 1.5 Ci of 22 NaCl (6 -17 Ci/mmol; PerkinElmer Life Sciences, Boston, MA) or 1.5 Ci of 45 CaCl 2 (0.5-2.0 Ci/mmol; Amersham Biosciences UK, Ltd., Little Chalfont, Buckinghamshire, UK) at 37°C for 5 min with or without various secretagogues, ␣-and ␤-scorpion venoms, and/or PbTx-3 in KRP buffer. After reaction, the cells were quickly washed four times with 1 ml of ice-cold KRP buffer. Then, the cells were solubilized with 1 ml of 10% Triton X-100. Radioactivity of 22 Na ϩ and 45 Ca 2ϩ in the cells was counted by an Aloka ARC-2005 gamma counter (Aloka Co., Ltd., Tokyo, Japan) and a Beckman LS-7000 liquid scintillation counter (Beckman Coulter Inc., Fullerton, CA), respectively. The influx of 22 Na ϩ and 45 Ca 2ϩ was calculated from the initial specific radioactivity of these ions in the incubation medium.
Catecholamine Secretion. Cells were incubated at 37°C for 5 min with or without carvedilol in the presence or absence of 100 M veratridine (final volume 1.0 ml). After the reaction, the incubation medium was immediately transferred to a test tube containing 4 ml of ice-cold 0.5 M perchloric acid. Catecholamines (norepinephrine and epinephrine) secreted into the incubation medium were adsorbed to aluminum hydroxide and estimated by the ethylenediamine condensation method with a fluorescence spectrophotometer (Hitachi 650-10S; Hitachi Ltd., Tokyo, Japan) with an excitation wavelength of 420 nm and an emission of 540 nm. ϩ RNA was purified using Oligotex-dT30ϽSuperϾ (Nippon Roche Co., Ltd., Tokyo, Japan), electrophoresed on a 1% agarose gel containing 6.3% formaldehyde in the running buffer [40 mM 3-(N-morpholino)propanesulfonic acid, pH 7.2, 0.5 mM EDTA, and 5 mM sodium citrate], then transferred to a nylon membrane (Hybond-N; Amersham Biosciences) in 20ϫ salinesodium citrate (SSC; 1ϫ SSC ϭ 0.15 M NaCl and 0.015 M sodium citrate) overnight, and cross-linked using a UV cross-linker (Funakoshi, Tokyo, Japan).
Northern Blot. cDNA fragments of hNE-Na (435-2666) and ␤ 1 -subunit (457-790), as well as glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (1.1 kb pair) were labeled with [␣-32 P]deoxycytidine 5Ј-triphosphate (Ͼ4000 Ci/mmol; Amersham Biosciences) using the BcaBEST labeling kit (Takara, Kyoto, Japan). The membrane was prehybridized and hybridized with hNE-Na probe at 42°C for 18 h in 6ϫ SSC, 10ϫ Denhardt's solution (2% bovine serum albumin fraction V, 2% polyvinylpyrrolidone, and 2% Ficoll 400), 50% formamide, 0.5% SDS, and 50 g/ml salmon sperm DNA; it was washed at 65°C in 2ϫ, 1ϫ, and 0.2ϫ SSC containing 0.1% SDS, each for 30 min twice, and subjected to autoradiography. The same membrane was sequentially hybridized to probes for ␤ 1 -subunit and GAPDH (BD Biosciences Clontech, Palo Alto, CA) after it was thoroughly washed in 0.1% SDS at 100°C to remove the former probe. Autoradiogram was quantified by a BAS 2000 bioimage analyzer (Fujifilm, Tokyo, Japan).
Statistical Analysis. Data are expressed as mean Ϯ S.D. The statistical evaluation of the data was performed by analysis of variance, followed by post hoc test. Values were considered statistically different when P was less than 0.05. Student ' s t test was used when two means of group were compared. 22 Na ϩ influx in a concentration-dependent manner. The suppressive effect of carvedilol (10 M) was not overcome even when the concentration of veratridine was increased to 560 M (Fig. 1B) .
Effect (Fig. 3A) . On the other hand, 56 mM K ϩ , an activator of voltage-dependent Ca 2ϩ channels, stimulated the influx of 45 Ca 2ϩ (2.12 Ϯ 0.13 nmol/10 6 cells) (Fig. 3B ). Carvedilol at concentrations of 0.1 to 10 M had no effect on 56 mM K Effect of Prolonged Exposure to Carvedilol on Veratridine-Induced 22 Na ؉ Influx in Combination with Either ␣-or ␤-Scorpion Venom and/or PbTx-3. We exam-ined whether/how prolonged exposure to carvedilol may alter 22 Na ϩ influx induced by veratridine, using several distinct classes of toxins of Na ϩ channels (Wada et al., 1992) . Cells were treated for 12 h with or without 10 M carvedilol, washed three times with 1 ml of KRP buffer, and used for 22 Na ϩ influx assay. ␣-Scorpion venom, which binds to site 3 between segment (S) 3 to 4 of domain IV (Rogers et al., 1996) , enhanced 22 Na ϩ influx evoked by veratridine, a toxin acting at site 2 of S6I (Trainer et al., 1996) (Fig. 4) . Similarly, ␤-scorpion venom, which interacts with site 4 (Catterall, 1992) , and PbTx-3, which binds to site 5 (Trainer et al., 1994) between S5IV and S6I, augmented veratridine-induced 22 Na ϩ influx. Furthermore, PbTx-3 in the presence of either ␣-or ␤-scorpion venom enhanced 22 Na ϩ influx induced by veratridine to a greater extent than did either toxin/venom alone. Pretreatment with carvedilol, however, rather suppressed veratridine-induced 22 Na ϩ influx. Furthermore, veratridine-induced 22 Na ϩ influx was also decreased in the presence of ␣-or ␤-scorpion venom and/or PbTx-3 in cells pretreated with carvedilol compared with nontreated cells. Nevertheless, these four toxins still enhanced veratridine- Fig. 4 , prolonged exposure to carvedilol reduced the functional activity of Na ϩ channels that showed pharmacological properties similar to that of nontreated cells. Next, we examined the cell surface expression of Na ϩ channels by using [ 3 H]STX binding. Surprisingly, when cells were treated with 10 M carvedilol for 3 to 72 h, increases in [ 3 H]STX binding were found between 3 and 72 h and reached a plateau at 12 h with the maximal increase of 61.2% (Fig. 5A) . Carvedilol also increased (Fig. 6) . 
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Effect of Carvedilol Treatment on Na ؉ Channel ␣-and ␤ 1 -Subunit mRNA Levels. From the results of Scatchard analysis (Fig. 6) , carvedilol-induced increase of [ 3 H]STX binding may implicate an up-regulation of Na ϩ channel proteins through its transcriptional events. Therefore, we estimated the steady-state levels of Na ϩ channel ␣-and ␤ 1 -subunit mRNAs in cells that had or had not been treated with 10 M carvedilol for 0, 1, 3, 6, 12, and 24 h. cDNA probes for hNE-Na and ␤ 1 -subunit hybridized, respectively, to one major ␣-subunit mRNA (9.4 kb) and to a single ␤ 1 -subunit mRNA (1.5 kb), as reported previously (Oh and Waxman, 1994; Klugbauer et al., 1995; Yamamoto et al., 1997) . When levels of ␣-and ␤ 1 -subunit mRNAs were normalized against those of GAPDH mRNA, densitometric analysis revealed that treatment by carvedilol did not significantly change the levels of ␣-subunit mRNA (102 Ϯ 4, 100 Ϯ 4, 99 Ϯ 4, 100 Ϯ 5, and 106 Ϯ 7% of control) (n ϭ 3) and ␤ 1 -subunit mRNA (98 Ϯ 5, 100 Ϯ 4, 102 Ϯ 7, 102 Ϯ 3, and 105 Ϯ 3% of control) (n ϭ 3) at 1, 3, 6, 12, and 24 h, respectively (data not presented).
Effects (Fig. 7) . BFA is an inhibitor of guanine nucleotide-exchange protein for ADPribosylation factor 1, a monomeric GTPase of the Ras superfamily, and blocks vesicle-mediated externalization of newly synthesized proteins from the trans-Golgi network (Moss and Vaughan, 1995; Morinaga et al., 1997 
Discussion

Suppression of Na
؉ Channel Activity by Carvedilol. In the present study, we demonstrated that carvedilol (1-100 M) reduced 22 Na ϩ influx evoked by veratridine in cultured bovine adrenal medullary cells (Fig. 1A) . Our study also provides evidence that the reduction of veratridine-induced 22 Na ϩ influx by carvedilol was not reversed by increasing concentrations of veratridine (Fig. 1B) , suggesting that carvedilol does not share common binding sites (site 2) with veratridine. Carvedilol decreased the veratridine-induced 45 Ca 2ϩ influx and catecholamine secretion similar to that for the 22 Na ϩ influx (Fig. 2) . In our previous study, veratridineinduced Na ϩ influx mediated through Na ϩ channels increased Ca 2ϩ influx via activation of voltage-dependent Ca 2ϩ channels and produced the exocytotic secretion of catecholamines (Wada et al., 1985) . Thus, it appears that carvedilol reduces veratridine-induced Na ϩ influx which, in turn, suppresses Ca 2ϩ influx through voltage-dependent Ca 2ϩ channels and finally produces the reduction of catecholamine secretion.
In addition to voltage-dependent Na ϩ channels, in bovine adrenal medullary cells two ion channels are involved in catecholamine secretion: nicotinic acetylcholine receptor-ion channels (activated by carbachol) and voltage-dependent Ca 2ϩ channels (activated by 56 mM K ϩ ) (Wada et al., 1985) . In the present study, we observed that carvedilol reduced the carbachol-evoked influx of 22 Na ϩ at 3 to 100 M and suppressed the 56 mM K ϩ -stimulated influx of 45 Ca 2ϩ , but only at a high concentration (100 M) (Fig. 3) . These findings suggest that carvedilol mainly interferes with voltage-dependent Na ϩ channels and nicotinic acetylcholine receptor-ion channels. The order of potency of the suppressive effect by carvedilol was voltage-dependent Na ϩ channels Ն nicotinic acetylcholine receptor-ion channels Ͼ Ͼ voltage-dependent Ca 2ϩ channels. Clinical plasma concentrations of carvedilol in humans reached 173 g/l (425 nM) after intravenous infusion of 12.5 mg, and 66 g/l (162 nM) after oral administration of 50 mg (Neugebauer et al., 1987) . Although these concentrations are about one order of magnitude lower than the concentration of 1 M that significantly reduced the activity of voltage-dependent Na ϩ channels (Fig. 1) , the concentrations used in the present study are comparable with those previously reported in other systems such as cultured human pulmonary artery vascular smooth muscle cells (Ohlstein et al., 1993) and cultured rat cerebellar granule cells (Lysko et al., 1994) .
Up-Regulation of Na ؉ Channels by Carvedilol Treatment. Prolonged exposure of adrenal medullary cells to carvedilol enhanced [ 3 H]STX binding, which reached a plateau at 12 h with the increase of 61% (Fig. 5) . Scatchard analysis revealed that carvedilol raised the number of [ 3 H]STX binding sites without altering the K d value (Fig. 6) .
Cycloheximide, an inhibitor of the ribosomal synthesis of proteins, halted the stimulatory effect of carvedilol on [ 3 H]STX binding (Fig. 7) , suggesting that carvedilol treat- ment induces the up-regulation of Na ϩ channels through a de novo synthesis of protein(s). The mRNA levels of the ␣-and ␤ 1 -subunit Na ϩ channels, however, were not changed by carvedilol treatment. A simple interpretation of these results is that carvedilol may stimulate the translational or posttranslational step(s) of Na ϩ channel synthesis or may inhibit the internalization/degradation of Na ϩ channels. Yamamoto et al. (1996) also observed that treatment of cultured adrenal medullary cells with insulin up-regulates the functional Na ϩ channels without causing any change in the level of mRNA encoding the Na ϩ channel ␣-subunit. In the present study, brefeldin A, an inhibitor of vesicle-mediated externalization of newly synthesized proteins from the trans-Golgi network, abolished the up-regulation of Na ϩ channels by carvedilol (Fig. 7) . Several lines of evidence have indicated a regulatory role of protein kinase A in the production of constitutive transport vesicles from the trans-Golgi network of endocrine cells (Muñ iz et al., 1997) . Indeed, in the present study, H-89, an inhibitor of protein kinase A, abolished the stimulatory effect of carvedilol. These findings led us to hypothesize that carvedilol up-regulates Na ϩ channels via increasing vesicular trafficking from the trans-Golgi network, in which protein kinase A may be involved. Yoshimura et al. (1998) , however, reported that long-term treatment with the anticonvulsant carbamazepine up-regulates Na ϩ channels through a cycloheximide-sensitive but cyclic AMP-independent pathway in cultured adrenal medullary cells. Thus, the up-regulation of Na ϩ channels induced by Na ϩ channel blockers might be more complex than is generally acknowledged. Indeed, Na ϩ channels have been reported to be associated with various cytoskeletal proteins (Flucher and Daniels, 1989) at plasma membranes (Kordeli et al., 1990) . Little, however, is known as to the molecular machinery that regulates intracellular vesicular transport (Novick and Brennwald, 1993) of ion channels/receptors, including Na ϩ channels, toward plasma membranes or the internalization of cell surface Na ϩ channels (Dargent et al., 1994) . Therefore, it is interesting to characterize precisely the processes of externalization or internalization of Na ϩ channels induced by these Na ϩ channel blockers.
The clinical implication of the up-regulation of Na ϩ channels induced by carvedilol is not clear at present. When carvedilol increased cell surface number of [ 3 H]STX binding sites (Figs. 5 and 6 ), the functional activity of Na ϩ channels, such as Na ϩ influx, was rather suppressed in cells treated with carvedilol for 12 h (Fig. 4) . However, ␣ (site 3 toxin)-or ␤ (site 4 toxin)-scorpion venom, or PbTx-3 (site 5 toxin) enhanced the 22 Na ϩ influx induced by veratridine in the presence or absence of carvedilol. Therefore, it appears that carvedilol does not interact with these distinct functional segments of the Na ϩ channel ␣-subunit (Trainer et al., 1994; Rogers et al., 1996) , and prolonged exposure to carvedilol does not alter the pharmacological features of Na ϩ channels. It may be that carvedilol accumulates in the plasma membranes during prolonged exposure and is not readily removed by washing because this drug is highly lipophilic (Neugebauer et al., 1987) , thus producing the continued suppression of Na ϩ channel gating (Fig. 4) . Therefore, carvedilol might produce a persistent suppressive effect on Na ϩ channels and exert long-lasting blocking actions. Further in vivo studies would clarify whether administration of carvedilol influences the Na ϩ channel activity in experimental animals.
In conclusion, carvedilol reduced the functional activity of voltage-dependent Na ϩ channels and subsequently up-regulated cell surface Na ϩ channels in cultured adrenal medullary cells. The present findings may add new pharmacological actions of carvedilol to our understanding in the treatment of heart failure and hypertension.
